GOG-3101 | TroFuse-20 Clinical Trial Update
In this episode, we dive into GOG‑3101 TroFuse‑20—a Phase 3, randomized, active‑controlled, open‑label, multicenter study evaluating MK‑2870 monotherapy versus Treatment of Physician’s Choice as secon...
5 Maalis 13min
The GOG Highlight Reel - January 2026
The GOG Foundation, Inc. and GOG Partners are thrilled to present the “The GOG Highlight Reel”, an ongoing Education Series that showcases clinical trials and other newsworthy education, from major me...
20 Helmi 2h 15min
KEYNOTE-B96 FDA APPROVAL REVIEW
16 Helmi 19min
Accrual Culture: Top Points for Site Selection - Feasibility
5 Helmi 15min
Accrual Culture: Top Points for Site Selection - Enrollement
The GOG Partners Leadership presents the “Accrual Culture: An Education Series on How to Build a Successful Clinical Trial Network.” The purpose of this on-demand education series is to share key comp...
30 Tammi 18min
2026 Cervical Cancer Awareness Month Wrap Up
30 Tammi 11min
GOG Highlight Reel - January 2025
The GOG Foundation, Inc. and GOG Partners are thrilled to present the “The GOG Highlight Reel”, an ongoing Education Series that showcases clinical trials and other newsworthy education, from major me...
16 Loka 20252h 33min
Research Algorithms, Clinical Trial Prioritization(s), Sequencing of Trials/Treatment
15 Loka 202515min
